LIVER TRANSPLANTATION. A SINGLE CENTER EXPERIENCE OF 100 CASES
https://doi.org/10.15825/1995-1191-2012-4-11-16
Abstract
A single center experience of first 100 liver transplantations (LTs) is summarized. Analysis of trends in cadaver donor population and waiting list status changes, and also of early and late postoperative complications are presented. 100 LTs were performed for 95 patients (pts), retransplantation – 4 pts; one patient received 3 liver transplants (female – 55 pts, male – 40 pts, mean age – 39.9 ± 12.1 years). Cumulative 1-year survival rate of pts by Kaplan–Meyer was 91%, 3-year – 83%. Biliary complications were revealed in 9% of pts during 2–9 months after LT. 77 pts have been regularly observed in outpatient clinic, mean age – 44 ± 9.2 years, male – 35, fema- le – 42, follow-up period – 1 months up to 13 years after LT. 3.9% remained invalid with limitation of ability to work, 61.8% have been working, 22.3% were capable to work, retirees were 10.5%. Development of preoperati- ve planning, adequate organ selection will allow to improve the results of LT. Study of hematopoietic stem cells role will expand tools of prognosis of posttransplant complications.
About the Authors
A. M. Granov
Russian Research Center of Radiology and Surgical Technologies, St. Petersburg
Russian Federation
Russian Federation
D. A. Granov
Russian Research Center of Radiology and Surgical Technologies, St. Petersburg
F. K. Zherebtsov
Russian Research Center of Radiology and Surgical Technologies, St. Petersburg
O. A. Gerasimova
Russian Research Center of Radiology and Surgical Technologies, St. Petersburg
V. V. Borovik
Russian Research Center of Radiology and Surgical Technologies, St. Petersburg
V. V. Osovskikh
Russian Research Center of Radiology and Surgical Technologies, St. Petersburg
D. N. Maystrenko
Russian Research Center of Radiology and Surgical Technologies, St. Petersburg
I. O. Rutkin
Russian Research Center of Radiology and Surgical Technologies, St. Petersburg
S. P. Tsurupa
Russian Research Center of Radiology and Surgical Technologies, St. Petersburg
I. I. Tileubergenov
Russian Research Center of Radiology and Surgical Technologies, St. Petersburg
S. V. Shapoval
Russian Research Center of Radiology and Surgical Technologies, St. Petersburg
T. G. Mikhaylichenko
Russian Research Center of Radiology and Surgical Technologies, St. Petersburg
References
1. Андрейцева О.И. Возможности ортотопической трансплантации печени при лечении больных с терминальными поражениями печени // Consilium medicum. 2004. No 6. C. 414–421.
2. Герасимова О.А., Гранов Д.А., Жеребцов Ф.К., Бо- ровик В.В. Первый опыт применения телбивудина у больных после трансплантации печени // Вестник трансплантологии и искусcтвенных органов. 2010. Том XII. No 1. С. 33–38.
3. Гранов Д.А., Герасимова О.А., Жеребцов Ф.К. Основ- ные принципы отбора на трансплантацию пече- ни и динамика листа ожидания в ЦНИРРИ (1998– 2006 гг.) // Стационарозамещающие технологии. Ам- булаторная хирургия. 2007. No 2 (26). C. 17–19.
4. Готье С.В., Мойсюк Я.Г., Ибрагимова О.С. Орган- ное донорство и трансплантация в Российской Феде- рации в 2009 г.: II сообщение регистра Российского трансплантологического общества // Вестник транс- плантологии и искусственных органов. 2010. Т. XII. No 3. С. 6–15.
5. Михайличенко Т.Г., Герасимова О.А., Жеребцов Ф.К. Некоторые теоретические аспекты комплексного клинико-психологического исследования больных аутоиммунными заболеваниями с исходом в цир- роз перед трансплантацией печени // Вестник транс- плантологии и искусственных органов. 2010. Т. XII. No 3. C. 62–68.
6. Brown R.S., Lake J.R. The survival impact of liver transplantation the MELD era, and the future for organ allocation and distribution // Am. J. Transplant. 2005. Vol. 5. P. 203–205.
7. Fischer L., Trunečka P., Ericzon B.G. et al. Pharmaco- kinetics for once-daily versus twice-daily tacrolimus formulations in de novo liver transplantation: a randomized, open-label trial // Liver Transpl. 2011. Vol. 17 (2).
8. P. 167–177.
9. Friman S., Foss A., Ericzon B.G. et al. Liver transplan-
10. tation for cholangiocarcinoma: selection is essential for acceptable results // Scand. J. Gastroenterol. 2011. Vol. 46 (3). P. 370–375.
11. Gordon F.D., Kwo P., Vargas H. Treatment of hepatitis C in liver transplant recipients // Liver Transplant. 2009. Vol. 15. P. 126–135.
12. Gautam M., Cheruvattath R., Balan V. Recurrence of au- toimmune liver disease after liver transplantation: A sys- tematic review // Liver Transpl. 2006. Vol. 12. P. 1813– 1824.
13. Liaw Y., Gane E., Leung N. et al. 2-year GLOBE Trial Results: Telbivudine is superior to Lamivudine in pati- ents with chronic hepatitis B. Gastroenterology. 2009. Vol. 136. P. 486–495.
14. Neuberger J., Gunson B., Hubscher S., Nightingale P. Immunosuppression affects the rate of recurrent prima- ry biliary cirrhosis after liver transplantation // Liver Transpl. 2004. Vol. 10. P. 488–491.
15. International data on organ donation and transplantation activity, waiting list and family refusals. Year 2010. // Newsletter transplant 2011. P. 31–46.
Review
For citations:
Granov A.M., Granov D.A., Zherebtsov F.K., Gerasimova O.A., Borovik V.V., Osovskikh V.V., Maystrenko D.N., Rutkin I.O., Tsurupa S.P., Tileubergenov I.I., Shapoval S.V., Mikhaylichenko T.G. LIVER TRANSPLANTATION. A SINGLE CENTER EXPERIENCE OF 100 CASES. Russian Journal of Transplantology and Artificial Organs. 2012;14(4):11-16. (In Russ.) https://doi.org/10.15825/1995-1191-2012-4-11-16
Views:
1710
Email this article 